Selective internal radiation therapy (SIRT) in primary or secondary liver cancer

L. Prompers*, J. Bucerius, B. Brans, Y. Temur, L. Berger, F.M. Mottaghy

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Most patients with a history of common solid tumors will in the end develop liver metastases. Next to that, primary liver cancer, is a frequent cancer with fatal liver failure in the majority of patients. Selective internal radiation therapy (SIRT), has gradually been introduced over the recent years and is a promising, innovative albeit palliative treatment modality. The specific clinical background with regard to the indication and methodology of SIRT is presented and discussed in this paper.
Original languageEnglish
Pages (from-to)253-257
Number of pages5
JournalMethods
Volume55
Issue number3
DOIs
Publication statusPublished - Nov 2011

Keywords

  • SIRT
  • Liver cancer
  • Yttrium-90-microspheres
  • Resin-based spheres
  • Glass spheres
  • UNRESECTABLE HEPATOCELLULAR-CARCINOMA
  • Y-90 MICROSPHERE THERAPY
  • ART BRACHYTHERAPY TREATMENT
  • HEPATIC METASTASES
  • (90)YTTRIUM MICROSPHERES
  • COLORECTAL-CANCER
  • DOSE DISTRIBUTION
  • BREAST-CANCER
  • SINGLE-CENTER
  • RADIOEMBOLIZATION

Fingerprint

Dive into the research topics of 'Selective internal radiation therapy (SIRT) in primary or secondary liver cancer'. Together they form a unique fingerprint.

Cite this